Literature DB >> 23905134

An Extra-adrenal Pheochromocytoma Presenting as Malignant Hypertension-A Report of two cases.

Mahesh Kumar U1, Pankaj Pande, Ss Savita, Ashwin Pk, Balasaheb Ramling Yelikar.   

Abstract

Malignant hypertension is a complication of hypertension characterized by elevated blood pressure (200mm/140mm Hg), is considered a medical emergency and is rarely secondary to paraganglioma. Malignant hypertension is unique in its relationship to a catecholamine secreting paraganglioma. We present two rare cases of malignant hypertension associated with paraganglioma of tonsil and urinary bladder.

Entities:  

Keywords:  Paraganglioma; Tonsil; Urinary bladder

Year:  2013        PMID: 23905134      PMCID: PMC3708229          DOI: 10.7860/JCDR/2013/5139.3046

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

Review 1.  Pheochromocytoma: presentation, diagnosis and treatment.

Authors:  Nicole Reisch; Mariola Peczkowska; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Hypertens       Date:  2006-12       Impact factor: 4.844

2.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

3.  Malignant paraganglioma of the urinary bladder. A case report.

Authors:  M S Ansari; A Goel; S Goel; L N Durairajan; A Seth
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

4.  Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.

Authors:  N van Duinen; D Steenvoorden; I P Kema; J C Jansen; A H J T Vriends; J P Bayley; J W A Smit; J A Romijn; E P M Corssmit
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

  4 in total
  1 in total

Review 1.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.